153 related articles for article (PubMed ID: 15062057)
1. [Effect of c-kit gene mutation on prognosis of gastrointestinal stromal tumor].
Ma DL; Liu XH; Bai CG; Xie Q; Feng F
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):140-4. PubMed ID: 15062057
[TBL] [Abstract][Full Text] [Related]
2. [Expression and mutation of c-kit gene in gastrointestinal stromal tumor].
Ma D; Liu X; Cai Z; Xie Q
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):461-4. PubMed ID: 12485499
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features of gastric stromal tumors.
Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma.
Ishikubo T; Akagi K; Kurosumi M; Yamaguchi K; Fujimoto T; Sakamoto H; Tanaka Y; Ochiai A
Jpn J Clin Oncol; 2006 Aug; 36(8):494-8. PubMed ID: 16844734
[TBL] [Abstract][Full Text] [Related]
5. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y
Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475
[TBL] [Abstract][Full Text] [Related]
6. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.
Hirota S; Nishida T; Isozaki K; Taniguchi M; Nakamura J; Okazaki T; Kitamura Y
J Pathol; 2001 Apr; 193(4):505-10. PubMed ID: 11276010
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of C-kit gene mutation in patients with large gastrointestinal stromal tumors.
Lin SC; Liu CL; Wang TI; Chang WS; Tzen CY; Huang MJ
J Gastroenterol Hepatol; 2006 Oct; 21(10):1604-8. PubMed ID: 16928224
[TBL] [Abstract][Full Text] [Related]
8. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
[TBL] [Abstract][Full Text] [Related]
9. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
10. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
Bernet L; Zuñiga A; Cano R
Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
[TBL] [Abstract][Full Text] [Related]
11. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
12. Effect of loss of heterozygosity of the c-kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors.
Kikuchi H; Yamamoto M; Hiramatsu Y; Baba M; Ohta M; Kamiya K; Tanaka T; Suzuki S; Sugimura H; Kitagawa M; Kanai T; Kitayama Y; Kanda T; Nishikura K; Konno H
Cancer Sci; 2007 Nov; 98(11):1734-9. PubMed ID: 17894554
[TBL] [Abstract][Full Text] [Related]
13. Multiple gastrointestinal stromal tumors with a germline c-kit mutation.
Kim HJ; Lim SJ; Park K; Yuh YJ; Jang SJ; Choi J
Pathol Int; 2005 Oct; 55(10):655-9. PubMed ID: 16185297
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of c-kit gene mutations in gastrointestinal stromal tumors].
Hou YY; Sun MH; Tan YS; Wei YK; Lu XY; Zhang TM; Du X; Wang J; Zhu XZ
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):89-92. PubMed ID: 15059325
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
[TBL] [Abstract][Full Text] [Related]
16. Histopathological features and clinical course of the gastrointestinal stromal tumors.
Di Matteo G; Pescarmona E; Peparini N; Di Matteo FM; Zeri KP; Mascagni D; Mele R; Maturo A; Redler A; De Antoni E
Hepatogastroenterology; 2002; 49(46):1013-6. PubMed ID: 12143190
[TBL] [Abstract][Full Text] [Related]
17. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
[TBL] [Abstract][Full Text] [Related]
18. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.
Kinoshita K; Hirota S; Isozaki K; Ohashi A; Nishida T; Kitamura Y; Shinomura Y; Matsuzawa Y
J Pathol; 2004 Jan; 202(1):80-5. PubMed ID: 14694524
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
[TBL] [Abstract][Full Text] [Related]
20. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.
Antonescu CR; Viale A; Sarran L; Tschernyavsky SJ; Gonen M; Segal NH; Maki RG; Socci ND; DeMatteo RP; Besmer P
Clin Cancer Res; 2004 May; 10(10):3282-90. PubMed ID: 15161681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
